Eurofins-Cerep SA (EPA:ALECR)
16,100
0.00 (0.00%)
Jan 20, 2026, 11:30 AM CET
Eurofins-Cerep Revenue
In the year 2025, Eurofins-Cerep had annual revenue of 41.10M EUR with 1.51% growth. Eurofins-Cerep had revenue of 22.84M in the half year ending December 31, 2025, with 1.32% growth.
Revenue
41.10M
Revenue Growth
+1.51%
P/S Ratio
1.95
Revenue / Employee
208.62K
Employees
197
Market Cap
80.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41.10M | 611.02K | 1.51% |
| Dec 31, 2024 | 40.49M | -3.58M | -8.13% |
| Dec 31, 2023 | 44.07M | -3.58M | -7.51% |
| Dec 31, 2022 | 47.65M | 6.01M | 14.45% |
| Dec 31, 2021 | 41.63M | 8.97M | 27.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
| Klea Holding | 22.17M |
| ABIONYX Pharma | 4.06M |
| Adocia | 3.85M |
| Valerio Therapeutics Société anonyme | 2.57M |